Adalimumab for treatment of very early onset inflammatory bowel disease
Adalimumab for treatment of very early onset inflammatory bowel disease
About this item
Full title
Author / Creator
Xie, Yao , Liu, Li-Li , Jiang, Yi , Tang, Ze-Zhong , Sun, Guo-Yu and Hou, Xin-Lin
Publisher
China: Lippincott Williams & Wilkins Ovid Technologies
Journal title
Language
English
Formats
Publication information
Publisher
China: Lippincott Williams & Wilkins Ovid Technologies
Subjects
More information
Scope and Contents
Contents
To the Editor: The incidence of inflammatory bowel disease (IBD) has been increasing in recent years; nevertheless, neonatal IBD with IL10-RA gene mutations are rare with great therapeutic challenges. On admission, laboratory examinations revealed the C-reactive protein level (CRP), erythrocyte sedimentation rate (ESR) and complete blood count were...
Alternative Titles
Full title
Adalimumab for treatment of very early onset inflammatory bowel disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b9bd5cb7204f406c8ed6d2a151e878a8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b9bd5cb7204f406c8ed6d2a151e878a8
Other Identifiers
ISSN
0366-6999
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000000528
